In Silico Modeling: A Game Changer for CiPA
In the realm of pharmaceutical research and drug development, in silico modeling has emerged as a transformative approach. Particularly in the context of the Comprehensive in vitro Proarrhythmia Assay (CiPA) initiative, these computational techniques are proving invaluable. They provide researchers with advanced tools to predict cardiac safety without relying solely on traditional in vivo...
0 Comments 0 Shares 725 Views 0 Reviews